Activation Conditions Determine Susceptibility of Murine Primary T-lymphocytes to Retroviral Infection

Journal of Gene Medicine

Volumn 1, Issue 5, 1999, Pages 341-351

  Hagani, Andrea B ^a,c   Rivière, Isabelle ^b   Tan, Cuiwen ^a   Krause, Anja ^a   Sadelain, Michel ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Sloan Kettering Institute ^*  (United States)

Author keywords

Adoptive immunotherapy; HIV; Retroviral gene transfer; T lymphocyte; Th1 Th2 T cell subsets

Indexed keywords

ANIMALIA; HUMAN IMMUNODEFICIENCY VIRUS; MURINAE; VESICULAR STOMATITIS VIRUS;

ANIMAL; ARTICLE; C57BL MOUSE; CD4+ T LYMPHOCYTE; CELL CULTURE; CELL SURVIVAL; CYTOLOGY; GENE THERAPY; GENE TRANSFER; GENE VECTOR; GENETICS; HUMAN; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; LYMPHOCYTE SUBPOPULATION; MALE; MOUSE; RETROVIRUS; T LYMPHOCYTE; VIROLOGY;

ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CELL SURVIVAL; CELLS, CULTURED; GENE THERAPY; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; HUMANS; LYMPHOCYTE ACTIVATION; LYMPHOCYTE SUBSETS; MALE; MICE; MICE, INBRED C57BL; RETROVIRIDAE; T-LYMPHOCYTES;

EID: 0033182903     PISSN: 1099498X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(sici)1521-2254(199909/10)1:5<341::aid-jgm58>3.0.co;2-j     Document Type: Article

References (44)

1. Bunnell BA, Muul LM, Donahue REBlaes RMMorgan RA, High-efficiency retroviral-mediated gene transfer into human and nonhuman primate peripheral blood lymphocytes. Proc Natl Acad Sci U S A 1995; 92: 7739-7743.
2. Gallardo HF, Tan C, Ory D, Sadelain M. Recombinant retroviruses pseudotyped with the vesicular stomatitis virus G glycoprotein mediate both stable gene transfer and pseudo-transduction in human peripheral blood lymphocytes. Blood 1997; 90: 952-957.
3. Sadelain M. Methods for retroviral-mediated gene transfer in murine primary T-lymphocytes. In Gene therapy protocols: methods in molecular biology, Robbins P (ed). Totowa, NJ: Humana Press, 1997; 241-248.
4. Miller DG, Adam MA, Miller AD. Gene transfer by retrovirus vectors occurs only in cells that are actively replicating at the time of infection. Mol Cell Biol 1990; 10: 4239-4242.
5. Roe TY, Reynolds TC, Yu G, Brown PO. Integration of murine leukemia virus DNA depends on mitosis. EMBO J 1993; 12: 2099-2108.
6. Hajihosseini M, Iavachev L, Price J. Evidence that retroviruses integrate into post-replication host DNA. EMBO J 1993; 12: 4969.
7. Miller AD. Cell-surface receptors for retroviruses and implications for gene transfer. Proc Natl Acad Sci U S A 1996; 93: 4969-4974.
8. Kim JW, Closs EI, Albritton LM, Cunningham JM. Transport of cationic amino acids by the mouse ecotropic retrovirus receptor. Nature 1991; 352: 725-728.
9. Wang H, Kavanaugh MP, North RA, Rabat D. Cell-surface receptor for ecotropic murine retroviruses is a basic amino-acid transporter. Nature 1991; 352: 729-731.
10. Kavanaugh MP, Miller DG, Zhang W et al. Cell-surface receptors for gibbon ape leukemia virus and amphotropic murine retro-virus are inducible sodium-dependent phosphate symporters. Proc Natl Acad Sci U S A 1994; 91: 7071-7075.
11. Wilson CA, Eiden MV, Anderson WB, Lehel C, Olah Z. The dual-function hamster receptor for amphotropic murine leukemia virus (MuLV), 10A1 MuLV, and gibbon ape leukemia virus is a phosphate symporter. J Virol 1995; 69: 534-537.
12. Wyatt R, Sodroski J. The HIV-1 envelope glycoproteins: fusogens, antigens, and immunogens. Science 1998; 280: 1884-1888.
13. Albritton LM, Tseng L, Scadden D, Cunningham JM. A putative murine ecotropic retrovirus receptor gene encodes a multiple membrane-spanning protein and confers susceptibility to virus infection. Cell 1991; 57: 659-666.
14. Scott-Taylor T, Gallardo HF, Gansbacher B, Sadelain M. Adenovirus-facilitated infection of human cells with ecotropic retrovirus. Gene Ther 1998; 5: 621-629.
15. Kurre P, Kiem HP, Morris J, Heyward S, Battini JL, Miller AD. Efficient transduction by an amphotropic retrovirus vector is dependent on high-level expression of the cell surface virus receptor. J Virol 1999; 73: 495-500.
16. Orlic D, Girard LJ, Jordan CT, Anderson SM, Cline AP, Bodine DM. The level of mRNA encoding the amphotropic retrovirus receptor in mouse and human hematopoietic stem cells is low and correlates with the efficiency of retrovirus transduction. Proc Natl Acad Sci U S A 1996; 93: 11097-11102.
17. Chu P, Lutzko C, Stewart AK, Dube ID. Retrovirus-mediated gene transfer into human hematopoietic stem cells. J Mol Med 1998; 76: 184-192.
18. Best S, Le Tissier PR, Stoye JP. Endogenous retroviruses and the evolution of resistance to retroviral infection. Trends Microbiol 1997; 5: 313-318.
19. Rousseau V, Cremer I, Lauret E, Riviere I, Aguet M, De Maeyer E. Antiviral activity of autocrine interferon-beta requires the presence of a functional interferon type I receptor. J Interferon Cytokine Res 1995; 15: 785-789.
20. Balzarini J, De Clercq E. Analysis of inhibition of retroviral reverse transcriptase. Methods Enzymol 1996; 275: 472-502.
21. Vieillard V, Lauret E, Rousseau V, De Maeyer E. Blocking of retroviral infection at a step prior to reverse transcription in cells transformed to constitutively express interferon beta. Proc Natl Acad Sci U S A 1994; 91: 2689-2693.
22. + T-lymphocytes suppresses HIV replication. Immunology 1989; 66: 628-630.
23. + T-cells. Science 1995; 270: 1811-1815.
24. + T-cells. J Immunol 1990; 144: 2961-2966.
25. + T-cells suppress human immunodeficiency virus replication by inhibiting viral transcription. Proc Natl Acad Sci U S A 1995; 92: 2308-2312.
26. Burns JC, Friedmann T, Direver W, Burrascano M, Yee JK. Vesicular stomatitis virus G glycoprotein pseudotyped retroviral vectors: Concentration to very high titer and efficient gene transfer into mammalian and nonmammalian cells. Proc Natl Acad Sci U S A 1993; 90: 8033-8037.
27. Schlegel R, Tralka TS, Willingham MC, Pastan I. Inhibition of VSV binding and infectivity by phosphatidylserine: is phosphatidylserine a VSV-binding site? Cell 1983; 32: 639-646.
28. Mastromarino P, Conti C, Goldoni P, Hauttecoeur B, Orsi N. Characterization of membrane components of the erythrocyte involved in vesicular stomatitis virus attachment and fusion at acidic pH. J Gen Virol 1987; 68(Pt 9): 2359-2369.
29. Riviere I, Sadelain M. Methods for the construction of retroviral vectors and the generation of high titer producers. In Gene therapy protocols: Methods in molecular biology, Robbins P (ed). Totowa, NJ: Humana Press, 1997; 59-78.
30. Danos O, Mulligan RC. Safe and efficient generation of recombinant retroviruses with amphotropic and ecotropic host ranges. Proc Natl Acad Sci U S A 1988; 85: 6460-6464.
31. Markowitz DG, Goff SP, Bank A. Safe and efficient ecotropic and amphotropic packaging lines for use in gene transfer experiments. Trans Assoc Am Physicians 1988; 101: 212-218.
32. Ory DS, Neugeboren BA, Mulligan RC. A stable human-derived packaging cell line for production of high titer retrovirus/ vesicular stomatitis virus G pseudotypes. Proc Natl Acad Sci U S A 1996; 93: 11400-11406.
33. Rivière I, Sunshine MJ, Littman DR. Regulation of IL-4 expression by activation of individual alleles. Immunity 1998; 9: 217-228.
34. Sadelain M, Wang C-HJ. Antoniou M, Grosveld F, Mulligan RC. Generation of a high-liter retroviral vector capable of expressing high levels of the human β-globin gene. Proc Natl Acad Sci U S A 1995; 92: 6728-6732.
35. Mosmann TR, Coffman RL. Annu Rev Immunol 1989; 7: 145.
36. + T-cell subset with an unrestricted cytokine profile. J Immunol 1989; 143: 518-525.
37. H2 predominance in HIV-infected individuals. Science 1994; 265: 248-252.
38. Foli A, Saville MW, Baseler MW, Yarchoan R. Effects of the Th1 and Th2 stimulatory cytokines interleukin-12 and interleukin-4 on HIV replication. Blood 1995; 85: 2114-2123.
39. Weissman D, Daucher J, Barker T, Adelsberger J, Baseler M, Fauci AS. Cytokine regulation of HIV replication induced by dendritic cell-CD4-positive T-cell interactions. AIDS Res Hum Retroviruses 1996; 12: 759-767.
40. Bird JJ, Brown DR, Mullen AC et al. Helper T-cell differentiation is controlled by the cell cycle. Immunity 1998; 9: 229-237.
41. Pardoll DM. Cancer vaccines. Nat Med 1998; 4: 525-531.
42. Davies JD, Martin G, Phillips J, Marshall SE, Cobbold SP, Waldmann H. T-cell regulation in adult transplantation tolerance. J Immunol 1996; 157: 529-533.
43. Cameron MJ, Arreaza GA, Delovitch TL. Cytokine and costimuIation mediated therapy of IDDM. Crit Rev Immunol 1997; 17: 537-544.
44. Chen LZ, Hochwald GM, Huang C, et al. Gene therapy in allergic encephalomyelitis using MBP - specific T cells engineered to express latent TGF-ß1. Proc Natl Acad Sci U S A 1998; 95: 12516-12521.